Passions

Film

European history

Running

Experience

ARCH Venture Partners Co-Leads Xaira Therapeutics $1 Billion Series A Funding

April 24, 2024

Cooley advised ARCH Venture Partners, which co-led a $1 billion Series A funding round in Xaira Therapeutics. Partners Colleen Badgley, Danielle Naftulin and Dave Peinsipp led the Cooley team advising ARCH, a venture capital firm catalyzing discoveries that prevent, detect and cure disease.

Related contacts

David Peinsipp
Partner, San Francisco
Colleen Badgley
Partner, Seattle
Willy Cowles
Associate, Seattle
Bin Wang
Special Counsel, Palo Alto
Zack Gong
Associate, Shanghai
Tom James
Associate, San Francisco
Thomas Welk
Senior Counsel, San Diego
Carly Robinson
Associate, Reston
Sharon Connaughton
Special Counsel, Washington, DC
Elizabeth M. Morrison
Associate, Miami

Related Practices & Industries

Admissions and credentials

California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.